Podcasts about DRS

The August 2026 recall showcases five incredible interviews highlighting recent advances in headache medicine. The episode begins with Dr. Patricia Pozo-Rosich discussing the latest advancements in headache medicine, focusing on key research findings from 2025. The episode continues with Dr. Jennifer Robblee discussing the latest consensus on refractory migraine. In the third episode of this series, Dr. Michael Eller discusses the implications of CGRP therapies in migraine treatment.  The recall concludes with a two-part discussion featuring Drs. Tesha Monteith and Peter Goadsby, who highlight major developments in headache medicine presented at the 2026 AAN Annual Meeting.   Podcast links:    The Best of Headache Medicine from 2025: A Year in Review   Refractory Headache Disorders, New Consensus, and Emergency Department Migraine Guidelines   CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke   Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 1  Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 2  Article links:  Reaching International Consensus on the Definition of Refractory Migraine Using the Delphi Method 2025 Guideline Update to Acute Treatment of Migraine for Adults in the Emergency Department CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke   Disclosures can be found at Neurology.org. 

In this episode of the American Shoulder and Elbow Surgeons Podcast, hosts Dr. Brian Waterman and Peter Chalmers interview Drs. Mike Amini, Paul Favorito, and Mark Mighell about Subscapularis-Sparing Total Shoulder Arthroplasty. This episode is sponsored by Depuy Synthes.  https://www.jnjmedtech.com/en-US/product/inhance-shoulder-system

This week we review a recent book entitled Reimagining a Child's Heart: The Lone Pines of Congenital Cardiology which was recently published by Springer and which was authored by Dr. Thomas J. Kulik and Dr. Macdonald Dick. Drs. Kulik and Dick recount the innumerable steps in discovery that led to what the authors view as one of the pinnacles of achievement in our field, namely the palliation of children with HLHS and single ventricle disease. Dr. Kulik tragically passed suddenly in 2021 but his friend and colleague Dr. Dick completed the book that Dr. Kulik had spent over a decade toiling over. This week we sit down with Dr. Dick and also, briefly, Dr. Roberta Williams and Dr. Kulik's wife Ms. Linda Kulik to discuss the book, Dr. Kulik's legacy, mentorship and more. Dr. Dick also shares with us what he believes are the keys to a successful retirement. This is a rare opportunity to listen to some of the truest pioneers of our field, 'Lone Pines" themselves share their insights and warm stories. For those interested, this is one of many sites to obtain the book:https://www.amazon.com/dp/3031886070?lv=shuf&channelId=500&plpRedirect=mhFallbackAlso mentioned in this episode are 2 prior episodes including our conversation with Dr. Michael Freed and our conversation with Ms. Patricia Meisol and links are below:https://podcasts.apple.com/us/podcast/pediheart-podcast-203-a-conversation-with-dr-michael-freed/id1341472214?i=1000556610155https://podcasts.apple.com/us/podcast/pediheart-podcast-320-the-extraordinary-life/id1341472214?i=1000677938143

In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing  MS.  For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.  Read more about the Fenebrutinib Trial. 

Drs. Montesi and Martinez explore how to define and monitor PPF, especially in non-IPF ILD. They describe advances in recognizing progression and the use of antifibrotic therapy, while also highlighting ongoing controversy over exact criteria and emphasizing the need to combine symptoms, lung function (FVC, DLCO), and CT imaging for careful, regular follow-up.

I sommerens sidste udgave af Tabloids jordomrejse med DRs korrespondenter sender vi Trine Maria Ilsøe afsted mod jobbet som USA-korrespondent. Hvad ved en garvet kriminalreporter som Ilsøe om amerikansk politik? Hvilke historier vil hun helst sende hjem? Og har tidligere USA-korrespondent Matias Seidelin kollegiale råd til, hvordan man finder de rigtige kilder og gode historier i det store, splittede land med præsident Trump i Det Hvide Hus? Vært: Marie Louise Toksvig.

In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions.  For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.  Read more about the Fenebrutinib Trial.  Disclosures can be found at Neurology.org. 

In part one of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the fenebrutinib trial and highlight the key takeaways that healthcare providers should be aware of.   For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.  Read more about the Fenebrutinib Trial. 

On this episode of Local Matters Health Matters, hosts Drs. Mabry & Lee are joined by local family physician Dr. Ernie Buchanan of Upper Cumberland Family Physicians and Peter Richards, a third-year medical student at LMU, to separate health facts from social media fiction. They discuss the science behind GLP-1 weight loss medications, high-protein diets, intermittent fasting, continuous glucose monitors, gut health, probiotics, and other popular wellness trends. The conversation offers practical, evidence-based advice to help listeners navigate today's health information with confidence while emphasizing healthy lifestyle habits over online hype. Listen To The Local Matters Podcast Today! The UC Now · News Talk 94.1

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs. Pierre-Yves Dumas and Samik Basu on their latest articles published in Blood. Dr. Dumas talks about "Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy" where the team was able to identify that ultra-low-burden FLT3-ITD microclones are associated with higher relapse risk and inferior relapse-free survival. Their work encourages the evaluation of FLT3 inhibitor strategies. Dr. Basu discusses "CD19 CAR T-cell therapy is feasible for patients with pemphigus vulgaris treated without lymphodepletion in the RESET-PV trial". In four patients, the treatment was well tolerated and supported CAR T-cell expansion and persistence, challenging the need for lymphodepletion and supporting chemotherapy-free approaches in autoimmune disease.

Drs. D.G. Hart, R. Scott Clark, and T. David Gordon react to a 1925 letter from J. Gresham Machen to a Southern presbyterian missionary. We talked about how the correspondence shed light on Machen the man and his past, present, and future as a growing churchman, as well as pragmatism, respectability, church decline, and the temptation to compromise.  See and read the letter here: https://presbycast.substack.com/p/machen-and-a-presbyterian-church Watch: https://www.youtube.com/watch?v=lBhP76o8CLQ

Dr. Brian Parker is the founder of Total Elixir and a physician dedicated to helping people optimize their health through nutrition, metabolic wellness, and lifestyle medicine. Drawing on years of clinical experience, he focuses on identifying and addressing the root causes of chronic disease rather than simply managing symptoms. Through Total Elixir, Dr. Parker empowers individuals with practical, evidence-based strategies to improve energy, longevity, and overall health, helping them take control of their well-being for the long term. In this episode, Drs. Brian and Brian talk about… (00:00) Intro (04:11) Dr. Brian's educational and personal bio (07:06) How Dr. Brian came up with the ultimate energy elixir (34:39) Dr. Brian's planned elixir to aid with sleep and falling asleep (40:04) How to get Total Elixir at a discounted price (see links below) (45:45) Brian's career plans and goals (54:02) Outro   For more information, please see the links below. Thank you for listening!   Links:   Dr. Brian Parker: Total Elixir: https://totalelixir.com Total Elixir Discount Code: Brian25   Dr. Brian Lenzkes:  Arizona Metabolic Health: https://arizonametabolichealth.com/ Low Carb MD Podcast: https://www.lowcarbmd.com/   HLTH Code: HLTH Code Promo Code: METHEALTH • • HLTH Code Website: https://gethlth.com

Drs. Garg and Mehta focus on challenges and solutions in providing retinal care for patients—especially those with diabetes—including barriers like socioeconomic factors, transportation, insurance, and the need for coordinated, team-based care with other medical specialists. They highlight initiatives such as diabetic eye screening days and emerging technologies like tele-ophthalmology, home OCT, and AI-driven screening and monitoring to improve access, continuity of care, and visual outcomes.

Join co-hosts Drs. Nick Strasser, and Pam Luk as they discuss patient factors and treatment considerations for ankle replacement and fusion with Drs. Constantine Demetracopoulos and Jesse Doty. For additional educational resources, visit AOFAS.org

In this episode, Dr. Andy Cutler is joined by Drs. Stephen Stahl and Jeffrey Strawn to discuss deprescribing practices in psychiatry. They explore why deprescribing is an essential clinical skill, how to determine whether a patient still needs a medication, dose, or combination, and how to approach tapering in a way that balances relapse prevention, withdrawal risk, and patient-centered care. The conversation also covers practical considerations for deprescribing antidepressants, antipsychotics, benzodiazepines, and sedative-hypnotics, with attention to common pitfalls and strategies for safer, more intentional medication management.  Stephen M. Stahl, MD, PhD, DSc (Hon.), is a psychiatrist, psychopharmacologist, and internationally recognized educator in clinical neuroscience and psychopharmacology. He is the author of widely used educational resources including Stahl's Essential Psychopharmacology, Stahl's Prescriber's Guide, and Stahl's Deprescriber's Guide, and his work focuses on translating complex neurobiology into practical clinical concepts for mental health clinicians.  Jeffrey R. Strawn, MD, FAACAP, is a Professor of Psychiatry, Pediatrics, and Clinical & Translational Pharmacology at the University of Cincinnati, Ohio. He is Director of the UC Anxiety Disorders Research Program and Associate Vice Chair of Research in the Department of Psychiatry & Behavioral Neuroscience at UC, and he is the author of Stahl's Deprescriber's Guide.  Andrew J. Cutler, MD, is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and EMA Wellness. He is a Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.  Resources  Strawn, JR, Stahl SM. Stahl's Deprescriber's Guide. Cambridge University Press; 2026. https://doi.org/10.1017/9781009642187  Fall Congress   Get $100 off NEI Fall Congress registration with code POD26. Go to https://nei.global/fall to sign up today!   Membership  As a valued NEI Podcast listener, Dr. Cutler's offering you 20% off new NEI Membership with code CUTLER20. Go to https://nei.global/member and join now!  Never miss an episode!

In this episode of SurgOnc Today, Drs. Geoffrey Young, Sonia Cohen, and Ashley Holder discuss considerations for and approaches to difficult sentinel node procedures for staging of cutaneous malignancies.

Listen in as Drs. Malcolm DeBaun and Saam Morshed chat about young femoral neck fractures. They discuss diagnosis and management of these patients in this high yield case series.  For additional educational resources visit OTA.org

Drs. Bunick and Shahriari discuss the emerging role of the OX40/OX40L pathway in atopic dermatitis, highlighting how targeting antigen-specific T cells may rebalance the immune system and potentially induce durable, off-drug remission. They review promising phase 2 and 3 data for agents like rocatinlimab and amlitelimab, emphasize encouraging safety profiles, and explore future innovations such as combination and bispecific approaches to improve both speed and durability of disease control.

The hosts of the Excalibur podcast Oh Gosh, Oh Golly, Oh Wow! - Drs. Anna Peppard, Christopher Maverick and J. Andrew Deman - reunite for one night only to talk about Chris Claremont's New Excalibur #1, in which Pete Wisdom helps get the band back together to help solve the murder of Dazzler. Plus, we look at two pages of the post-"House of M" Decimation one-shot, starring Pete and Courtney Ross.

Transforming your health is more fun with friends! Join Chef AJ's Exclusive Plant-Based Community. Become part of the inner circle and start simplifying plant-based living - with easy recipes and expert health guidance. Find out more by visiting: https://community.chefaj.com/ ORDER MY NEW BOOK SWEET INDULGENCE!!! https://www.amazon.com/Chef-AJs-Sweet-Indulgence-Guilt-Free/dp/1570674248 or https://www.barnesandnoble.com/w/book/1144514092?ean=9781570674242 GET MY FREE INSTANT POT COOKBOOK: https://www.chefaj.com/instant-pot-download MY BEST SELLING WEIGHT LOSS BOOK: https://www.amazon.com/dp/1570674086?tag=onamzchefajsh-20&linkCode=ssc&creativeASIN=1570674086&asc_item-id=amzn1.ideas.1GNPDCAG4A86S Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes. BROOKE GOLDNER, M.D. MEDICAL DOCTOR | PLANT-BASED HEALER | AUTHOR Dr. Goldner is a board certified medical doctor and the author of 3 best-selling books, Goodbye Lupus, Goodbye Autoimmune Disease, and Green Smoothie Recipes to Kick-Start Your Health & Healing. She has been featured on the front cover of Vegan Health & Fitness Magazine 3 times, including the recent cover of Fit Over Forty. She graduated from Carnegie Mellon University with honors for genetic research in leukemia and neurobiology, was a graduate of the Temple University School of Medicine, was Chief Resident at UCLA Harbor Residency, and holds a certificate in Plant-Based Nutrition from Cornell University. She is the founder of Website: https://www.goodbyelupus.com/?s2-ssl=yes I and creator of the Hyper-nourishing Protocol for Autoimmune Reversal. Dr. Goldner's People Magazine Article: https://people.com/woman-living-with-lupus-gets-unexpected-health-news-days-before-wedding-exclusive-real-life-love-8731791 Video on The Neuroscience of Creating A New Habit, Meeting Your Goals & Motivation: https://www.youtube.com/watch?v=mDbn4L0rPPc She has been featured in multiple documentaries such as Eating You Alive, Whitewashed, and The Conspiracy Against Your Health, has been featured on tv news and the Home & Family Show, as well as many radio shows and podcasts, and is a highly sought after keynote speaker, who shares the stage regularly with Drs. Ornish, Esselstyn, Bernard Greger and T. Colin Campbell, to name a few. She has been featured on the front cover of Vegan Health & Fitness Magazine 3 times, including the recent cover of Fit Over Forty. She is a regular contributor to T. Colin Campbell Center for Nutrition Studies and she is featured in the Journal of Disease Reversal reversing lupus in herself, as well as multiple cases studies in reversing end stage lupus nephritis (kidney failure) with her hyper-nourishing nutrition protocol. She is a graduate of Carnegie Mellon University with honors for genetic research in leukemia and neurobiology, was a graduate of the Temple University School of Medicine, was Chief Resident at UCLA-Harbor Residency, and is the sole autoimmune professor for the Plant-Based Nutrition Certification from Cornell University. She is a member of the Forbes Health Advisory Board, the founder of GoodbyeLupus.com and creator of the Hyper-nourishing Protocol for Autoimmune Reversal. Website & Social Media: Website: https://www.goodbyelupus.com/?s2-ssl=yes Instagram: https://www.instagram.com/goodbyelupus/ Facebook: https://www.facebook.com/DrGoldner Youtube: https://youtube.com/brookegoldnermd TIK TOK @GoodbyeLupus Clubhouse @GoodbyeLupus Free Smoothie Recipes: https://smoothieshred.com/smoothie-recipes/.

Dr. Philip Ovadia is a board-certified heart surgeon on a mission to help people stay off his operating table. After overcoming his own struggles with obesity and poor metabolic health, he shifted his focus from treating advanced heart disease to preventing it by addressing its root causes. As the bestselling author of Stay Off My Operating Table, Dr. Ovadia challenges conventional thinking about heart health and advocates for nutrition, metabolic health, and lifestyle as the foundation for preventing cardiovascular disease. Through his clinical work, writing, and education, he empowers people to take control of their health long before surgery becomes necessary. In this episode, Drs. Brian and Philip talk about… (00:00) Intro (01:21) Dr. Ovadia's personal health journey  (05:09) Insulin resistance and heart disease (09:29) Insulin resistance, inflammation, and imaging (25:44) GLP medications and heart disease risk (28:47) Why meat is essential for human health (33:17) How Dr. Ovadia's colleagues have reacted to his unconventional dietary views and how the medical field is reacting to the keto/low carb revolution (39:25) Various lab tests and plaque progression (41:19) Gut health and the carnivore diet (42:54) Fermentation and detoxifying foods (46:29) Outro For more information, please see the links below. Thank you for listening! Links: Please consider supporting us on Patreon: https://www.lowcarbmd.com/ Dr. Philip Ovadia: Books: https://ovadiahearthealth.com/books/ Website: https://ovadiahearthealth.com/ X: https://x.com/ifixhearts Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author Dr. Tro Kalayjian:  Website: https://toward.health Twitter: https://twitter.com/DoctorTro IG: https://www.instagram.com/doctortro/ Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.  Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://toward.health/community/

In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data.  For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting.  Read more about the Fenebrutinib Trial.  Disclosures can be found at Neurology.org.   

The future of sports medicine isn't shaped solely in the operating room—it is also driven by visionary leadership, collaboration, education, and innovation. Live from the AOSSM Annual Meeting in Seattle, Drs. Catherine Logan and Ashley Bassett sit down with Corey Parker, MPA, the newly appointed CEO of the American Orthopaedic Society for Sports Medicine (AOSSM), to discuss his vision for one of the world's leading sports medicine organizations.With more than two decades of executive leadership experience in healthcare, academic medicine, and national physician organizations, Corey shares what drew him to AOSSM and how he plans to help the society continue advancing education, research, advocacy, and member engagement in an era of rapid change.The conversation explores how AOSSM is preparing surgeons for emerging technologies like artificial intelligence and biologics, expanding mentorship and leadership opportunities for early-career members, and strengthening collaboration across the multidisciplinary sports medicine team. Corey also discusses the importance of serving both academic and private practice surgeons while ensuring the organization remains innovative, financially strong, and increasingly valuable to its members.Whether you're a resident just beginning your career or a seasoned sports medicine surgeon, this episode offers an inside look at the leadership shaping the future of our specialty.In This Episode Corey Parker's journey to becoming CEO of AOSSM  Why AOSSM continues to be a global leader in sports medicine  Supporting residents, fellows, and early-career surgeons through mentorship and leadership development  Strengthening connections between academic and private practice sports medicine physicians  Developing the next generation of leaders within AOSSM  Building stronger partnerships across the sports medicine care team  Corey's vision for the future of AOSSM and the legacy he hopes to leave Key Takeaways Leadership is essential to advancing sports medicine beyond clinical innovation.  Lifelong education and evidence-based guidance remain central to helping surgeons navigate an evolving field.  Mentorship and early career engagement are critical investments in the future of the specialty.  Collaboration across physicians, therapists, athletic trainers, researchers, and industry drives better patient care.  A strong professional society must continue evolving while remaining focused on its mission and its members. About Our GuestCorey Parker brings more than 20 years of progressive executive leadership in healthcare, academic medicine, and national medical societies. He currently serves as Chief Operating Officer of the American Association of Neurological Surgeons, where he oversees a complex enterprise of 65 staff and a combined operating budget exceeding $30 million. Previously, he served as Executive Director of Surgical Accreditation at the Accreditation Council for Graduate Medical Education, where he led accreditation efforts for orthopedic surgery and other surgical specialties nationwide. Earlier leadership roles within major academic health systems further reflect his expertise in operational excellence, financial stewardship, and large-scale team development.Parker will join the AOSSM professional team on April 6, 2026. He succeeds CEO Greg Dummer, who announced his intent to retire last August. Dummer has served as CEO since July 2016 and will remain with the organization through the 2026 Annual Meeting to support a smooth and successful transitionFollow The Sports Docs Podcast for conversations with leading surgeons, researchers, and innovators who are advancing the field of sports medicine through cutting-edge science, education, and collaboration.https://www.cloganmd.com/https://orthopedicnj.com/physicians/ashley-bassett

Dr. Adam Striker interviews Drs. Ashley Eltorai and Joseph Answine to gain a better understanding of what anesthesiologists should know about the deposition process. Listen in as they consider the elements of a malpractice claim, how to prepare for a deposition, how medical records can be used, and more. Recorded July 2026.

Need a quick, boots-on-the-ground revamp of your marriage? In today's interview clip, Jim Ramos talks to Drs. Paul and Virginia Friesen. They give 3 practical tips to make sure you come out victorious in your marriage.   Check out Paul and Virginia's book, The Marriage App: Unlocking the Irony of Intimacy https://tinyurl.com/marriageapp115 If you want the full interview, you can listen to it here! 

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning speaks with Drs. Michael Mack and Tom Nguyen about the proposed US Centers for Medicare & Medicaid Services changes to how cardiologists and cardiac surgeons interact during transcatheter aortic valve replacement (TAVR) procedures. Chapters 00:00 Intro 01:21 TAVR Heart Team 04:08 JANS 1+2, JACC TAVR vs SAVR 12:19 JANS 3, TAVR Short-Term Outcomes 14:06 JANS 4, SAVR Life Expectancy 17:44 JANS 5, WSJ TAVR Article 19:19 Video 1, Direct AA Cannulation Technique 21:23 Video 2, Endoscopic Redo TVR After CABG 24:25 Video 3, Gaudiani Cox-Maze III 27:33 Dr. Mack & Nguyen, TAVR Heart Team 51:12 Closing Dr. Mack explained the current heart team system, established in 2011 through collaboration with the US Food and Drug Administration (FDA) and CMS, which has been highly successful in ensuring safe and effective TAVR implementation. He argues that the proposed CMS changes could potentially dismantle this collaborative approach by allowing asynchronous patient evaluation and procedures to be performed by single operators without surgeon involvement. Dr. Nguyen provided insights from a system leader's perspective, noting that while the proposed changes raise significant concerns about patient care and data collection, some cardiologists argue that surgeons are already not actively involved in many programs, making the single operator model the norm in practice. Both expressed concern that without mandatory surgeon participation and TAVR registry involvement, smaller programs may adopt practices that lack proper accountability and could lead to inappropriate patient selection and outcomes, potentially creating more contentious debates between TAVR and surgical approaches. Joel also highlights recent JANS articles including a propensity-matched analysis comparing 10-year outcomes after SAPIEN 3 TAVR in the PARTNER 2 SAPIEN 3 Intermediate-risk Registry with surgery in the PARTNER 2A trial; a single-center retrospective study evaluated 61 patients who underwent cardiac surgery after prior TAVR during a 10-year period at a high-volume academic center; whether surgical aortic valve replacement (SAVR) should remain the first choice for aortic stenosis in patients with a life expectancy beyond five years; and an article examining the dramatic rise in the popularity of transcatheter aortic valves, early valve failure, and the impact it has on patients' lives. In addition, Joel explores axillary cannulation as a primary cannulation strategy, beating-heart endoscopic tricuspid valve replacement for high-risk redo patients after CABG and device-related tricuspid valve injury, and a Cox-Maze III operation combined with a left internal mammary artery (LIMA) to left anterior descending artery (LAD), as well as an ascending aortic replacement and aortic valve resuspension. Before closing, Joel highlights upcoming events in CT surgery. JANS Items Mentioned 10-Year Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement or Surgery in Intermediate-Risk Patients A Decade of Cardiac Surgery After Transcatheter Aortic Valve Replacement: Short-Term Clinical Outcomes at a High-Volume Center Great Debate: Surgical Aortic Valve Replacement Is First Choice for Aortic Stenosis in Patients With a Life Expectancy Beyond 5 Years A Breakthrough Heart Procedure Comes With Risky Tradeoffs CTSNet Content Mentioned Direct Axillary Artery Cannulation With the Open Seldinger Technique Endoscopic Redo Tricuspid Valve Replacement After CABG The Cox-Maze III Procedure Combined With Valve-Sparing Aortic Surgery and CABG Other Items Mentioned Centers for Medicare & Medicaid Services Database—TAVR Career Center CTSNet Events   Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

CardioNerds (Drs. Apoorva Gangavelli, Jenna Skowronski, and Hannah Every) discuss the continuum of prevention and heart failure with Drs. Anu Lala and Martha Gulati. Grounded in a clinical case of a 55-year-old woman with uncontrolled hypertension, type 2 diabetes, and obesity who is on the trajectory toward heart failure, this episode unpacks a paradigm-shifting framework from a joint HFSA/ASPC Scientific Statement. The discussion explores how prevention should not be siloed from heart failure management but rather integrated across a patient’s lifespan—from primary prevention in at-risk individuals, to secondary prevention in those with established heart failure, to tertiary prevention in patients with advanced therapies such as LVADs and heart transplantation. The experts highlight the importance of aggressive risk factor management, biomarker-guided screening, the AHA’s Life’s Essential 8, and the need for multidisciplinary collaboration and systems-level change to shift heart failure care from reactive to proactive. Audio editing for this episode was performed by CardioNerds Intern, Dr. Julia Marques Fernandes. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Prevention PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls Systemic inflammatory diseases are associated with an elevated CVD risk that has significant implications for early detection, risk Heart failure prevention is a continuum, not a checkpoint. Prevention applies at every stage—from at-risk (Stage A) through advanced/post-transplant care—and every clinical encounter is an opportunity to intervene. The AHA’s Life’s Essential 8 (diet, physical activity, nicotine exposure, sleep, BMI, blood lipids, blood glucose, blood pressure) forms the foundation at every stage. Hypertension carries the highest population-attributable risk for heart failure of any modifiable risk factor. In the Framingham Heart Study, 91% of patients with newly diagnosed HF had pre-existing hypertension. The SPRINT trial demonstrated a 38% reduction in HF incidence with intensive blood pressure targets (30 ng/L or NT-proBNP >125 ng/L) identify individuals at heightened risk for progression to symptomatic HF. The ACC/AHA/HFSA guidelines give a Class IIa recommendation for natriuretic peptide screening in at-risk patients. Urine albumin-to-creatinine ratio (UACR) is an underutilized screening tool that provides additional insight into CKM risk. The heart failure label does not close the prevention window—it accentuates it. Secondary prevention through GDMT optimization (quadruple therapy in HFrEF) and continued risk factor management remains critical. Tertiary prevention extends to post-LVAD and post-transplant patients, where hypertension, diabetes, obesity, and CKD management remain essential to long-term outcomes. Show notes For a comprehensive review, please review the full HFSA/ASPC Joint Scientific Statement: Lala A, Beavers C, Blumer V, et al. The Continuum of Prevention and Heart Failure in Cardiovascular Medicine. J Card Fail. 2026;32:75-105. doi:10.1016/j.cardfail.2025.06.013 1. What is the “continuum of prevention” framework, and how does it differ from traditional approaches to heart failure prevention? Historically, prevention and heart failure management have been treated as separate disciplines—primary prevention handled by preventive cardiologists and treatment managed by heart failure specialists. This joint HFSA/ASPC Scientific Statement reframes prevention as a dynamic, continuous process that spans a patient’s entire lifespan, regardless of HF stage or ejection fraction. The framework maps onto the ACC/AHA HF staging system: Primary prevention targets Stage A (“at risk”) and Stage B (“pre-HF”) patients to reduce the burden of incident HF. Secondary prevention targets Stage C (symptomatic) and Stage D (advanced) patients to reduce the impact of established HF through GDMT optimization and ongoing risk factor management. Tertiary prevention encompasses risk factor management in patients with LVADs or heart transplants—populations where hypertension, diabetes, and obesity still drive outcomes. The Central Figure of the statement illustrates that Life’s Essential 8 (blood pressure and lipid control, diabetes management, exercise, sleep, smoking cessation, weight management, and diet/nutrition counseling) forms the foundation at every stage, with pharmacologic and device-based therapies layered on top as disease progresses (Figure) 2. How do traditional risk factors drive heart failure, and what should clinicians prioritize? Hypertension carries the greatest population-attributable risk for HF. In the Framingham Heart Study (N=5,143), HTN was associated with a 2- to 3-fold increased risk of HF, with a population-attributable risk of 39% in men and 59% in women. The SPRINT trial showed a 38% reduction in HF incidence and 25% reduction in the primary composite outcome with intensive BP targets (30 ng/L or NT-proBNP >125 ng/L) are associated with heightened risk for progression to symptomatic HF. In the ARIC study, incorporating NT-proBNP reclassified 20% of older adults without HF into Stage B. Factors that affect interpretation include age, sex, obesity (lower values), and CKD (higher values). High-sensitivity cardiac troponin (hs-cTn): Concentrations above the 99th percentile are now included in the definition of Stage B HF. Troponin testing may complement natriuretic peptides, particularly when BNP/NT-proBNP values are ambiguous. Risk scores: The PCP-HF equation predicts 10-year HF risk using traditional risk factors plus QRS duration. The AHA PREVENT score incorporates HF risk calculation and includes markers of kidney function (albuminuria, eGFR), though it may underestimate risk in men and Black adults. The CKM syndrome staging framework (Stages 0–4) provides a holistic approach to assessing systemic cardiovascular-kidney-metabolic risk. 4. What are the key nontraditional risk factors and cross-cutting themes in heart failure prevention? Genetics: Pathogenic cardiomyopathy variants exist in ~1 in 200 individuals in the general population. The HFSA and ACMG recommend cascade testing to identify at-risk family members. Polygenic risk scores for dilated cardiomyopathy show a 3.8-fold risk for DCM in the top 10th percentile compared with the median. Sex-specific considerations: Women have 2.8 times the odds of developing HFpEF, while men have similarly increased odds of HFrEF. A complete obstetric/gynecologic history is essential—preeclampsia is associated with a 4-fold increased risk of HF. Peripartum cardiomyopathy requires intentional screening in high-risk populations. Cardiotoxic exposures: Clinicians should be aware of medications that cause direct myocardial toxicity (e.g., anthracyclines, trastuzumab, tyrosine kinase inhibitors). A team-based approach with pharmacists can help optimize medication selection and risk factor modification. Social determinants of health: Environmental exposures (air pollution, arsenic, lead, cadmium), food insecurity, financial instability, and limited healthcare access contribute to HF risk and progression. Equity-focused, risk-based prevention strategies are needed. Psychological health: Depression is common in HF and independently associated with worse outcomes. Screening with brief questionnaires (e.g., PHQ-2) is recommended. Meditation, spirituality, and holistic wellness approaches remain underutilized. 5. What systems-level and policy changes are needed to move the needle on heart failure prevention? Multidisciplinary HF prevention clinics that bring together preventive cardiologists, HF specialists, endocrinologists, nephrologists, dietitians, pharmacists, exercise physiologists, and genetic counselors are advocated by the statement. EHR-embedded risk stratification could proactively flag patients on a trajectory toward HF—analogous to sepsis alerts or fall risk flags—enabling earlier intervention, particularly for patients who may not reach a cardiologist. Cardiac rehabilitation remains underutilized, particularly in HFrEF (Class 2b recommendation) and HFpEF (not yet covered by Medicare). The HF-ACTION trial showed quality-of-life benefits, and the REHAB-HF trial showed particular benefit in older patients with HFpEF. Policy priorities include expanding insurance coverage for preventive screening and novel therapies (SGLT2i, GLP-1 RAs, nsMRAs), reducing clinical inertia through team-based care models with closer follow-up intervals, and ensuring equitable access to evidence-based therapies across diverse populations. Digital health and AI hold promise for personalized risk prediction, remote monitoring (e.g., wearable devices, implantable PA pressure monitors), and virtual cardiac rehabilitation to overcome access barriers. Figure  Lala A, Beavers C, Blumer V, et al. The continuum of prevention and heart failure in cardiovascular medicine: a joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology. J Card Fail. 2026;32(1):75-105. doi:10.1016/j.cardfail.2025.06.013) References Key references are bolded. Lala A, Beavers C, Blumer V, et al. The continuum of prevention and heart failure in cardiovascular medicine: a joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology. J Card Fail. 2026;32(1):75-105. doi:10.1016/j.cardfail.2025.06.013 Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032. doi:10.1161/CIR.0000000000001063 Lloyd-Jones DM, Allen NB, Anderson CAM, et al. Life’s Essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18-e43. doi:10.1161/CIR.0000000000001078 SPRINT Research Group, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103-2116. doi:10.1056/NEJMoa1511939 Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557-1562. doi:10.1001/jama.1996.03530440037034 Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997. doi:10.1001/jama.288.23.2981 Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145-153. doi:10.1056/NEJM200001203420301 Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117-2128. doi:10.1056/NEJMoa1504720 Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385(16):1451-1461. doi:10.1056/NEJMoa2107038 Solomon SD, McMurray JJV, Claggett B, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2022;387(12):1089-1098. doi:10.1056/NEJMoa2206286 Filippatos G, Anker SD, Agarwal R, et al. Finerenone reduces risk of incident heart failure in patients with chronic kidney disease and type 2 diabetes: analyses from the FIGARO-DKD trial. Circulation. 2022;145(6):437-447. doi:10.1161/CIRCULATIONAHA.121.057983 Solomon SD, McMurray JJV, Vaduganathan M, et al. Finerenone in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2024;391(16):1475-1485. doi:10.1056/NEJMoa2407107 Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232. doi:10.1056/NEJMoa2307563 Deanfield J, Verma S, Scirica BM, et al. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. Lancet. 2024;404(10454):773-786. doi:10.1016/S0140-6736(24)01498-3  Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023;389(12):1069-1084. doi:10.1056/NEJMoa2306963 Ndumele CE, Neeland IJ, Tuttle KR, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636-1664. doi:10.1161/CIR.0000000000001175 Khan SS, Matsushita K, Sang Y, et al. Development and validation of the American Heart Association’s PREVENT equations. Circulation. 2024;149(6):430-449. doi:10.1161/CIRCULATIONAHA.123.067626 Khan SS, Ning H, Shah SJ, et al. 10-year risk equations for incident heart failure in the general population. J Am Coll Cardiol. 2019;73(19):2388-2397. doi:10.1016/j.jacc.2019.02.057 Bozkurt B, Fonarow GC, Goldberg LR, et al. Cardiac rehabilitation for patients with heart failure: JACC expert panel. J Am Coll Cardiol. 2021;77(11):1454-1469. doi:10.1016/j.jacc.2021.01.030 Packer M. Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity. Circulation. 2018;137(15):1614-1631. doi:10.1161/CIRCULATIONAHA.117.032474 Lala A, Tayal U, Hamo CE, et al. Sex differences in heart failure. J Card Fail. 2022;28(3):477-498. doi:10.1016/j.cardfail.2021.10.006 Bozkurt B, Coats AJS, Tsutsui H, et al. Universal definition and classification of heart failure. Eur J Heart Fail. 2021;23(3):352-380. doi:10.1002/ejhf.2115 Hershberger RE, Givertz MM, Ho CY, et al. Genetic evaluation of cardiomyopathy—a Heart Failure Society of America practice guideline. J Card Fail. 2018;24(5):281-302. doi:10.1016/j.cardfail.2018.03.004 Levine GN, Cohen BE, Commodore-Mensah Y, et al. Psychological health, well-being, and the mind-heart-body connection: a scientific statement from the American Heart Association. Circulation. 2021;143(10):e763-e783. doi:10.1161/CIR.0000000000000947 Ezekowitz JA, Colin-Ramirez E, Ross H, et al. Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial. Lancet. 2022;399(10333):1391-1400. doi:10.1016/S0140-6736(22)00369-5

Drs. Berger and Denny discuss modern secondary prevention after non-cardioembolic ischemic stroke, focusing on short dual antiplatelet courses and individualized agent choice. They emphasize structured vascular risk management and look ahead to newer, safer antithrombotic options.

SPONSORED BY NURP Nurp is algorithmic trading designed specifically for busy professionals who don't have time to watch markets. Check out start.nurp.com/doctors  to learn more. --- What if some of the most widely accepted ideas about health deserve a second look? In this rerun episode of BS Free MD, Drs. May and Tim Hindmarsh welcome Dr. Jeremy Ayres and John Gusty for a wide-ranging conversation that challenges conventional thinking about medicine, chronic disease, and personal wellness. Drawing from decades of experience in natural health, Dr. Ayres shares his philosophy of helping the body heal by identifying underlying contributors to illness rather than focusing solely on symptom management. Together with John Gusty, co-founder of Naturally Better, the discussion explores patient empowerment, environmental influences on health, chronic disease, and the importance of asking better questions in modern healthcare. Whether you're a physician, healthcare professional, or simply someone interested in optimizing your health, this episode encourages thoughtful conversation and critical thinking about today's medical landscape. In This Episode Dr. Jeremy Ayres' journey into natural medicine Why true healing goes beyond treating symptoms Chronic disease through a holistic lens The relationship between lifestyle, nutrition, and long-term wellness Environmental factors that may influence health The importance of patient responsibility and education How Naturally Better was created to empower individuals with health knowledge Integrating conventional medicine with complementary approaches Why curiosity and open dialogue remain essential in healthcare Key Takeaways Healing often requires addressing underlying contributors—not just symptoms. Lifestyle choices can have a profound impact on long-term health. Patients who actively participate in their healthcare are better equipped to make informed decisions. Constructive conversations between conventional and complementary medicine can benefit everyone. Critical thinking and continuous learning remain essential in an evolving healthcare landscape. Listen & Subscribe If you enjoy conversations that challenge conventional thinking and explore new perspectives in medicine, subscribe to BS Free MD, leave a review, and share this episode with a colleague or friend. Disclaimer: The opinions expressed by guests are their own and are intended for educational purposes. This podcast does not provide individualized medical advice. Always consult a qualified healthcare professional regarding medical decisions. This title also aligns well with the original branding while improving SEO by including both guest names and the episode's central theme. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of the Nutrition in Clinical Practice Podcast, Drs. Nankani and Dawood discuss their research examining demographic and geographic disparities in malnutrition and gastrointestinal cancer mortality among older adults in the United States. Using more than two decades of CDC WONDER data, they explore trends in GI cancer and malnutrition rates, differences across race, ethnicity, sex, and geographic regions, and the factors that may contribute to these persistent disparities. Tune in to learn how these findings can inform future research and clinical strategies to improve nutrition care and outcomes for older adults with gastrointestinal cancers. Business Corporate by Alex Menco | alexmenco.net Music promoted by www.free-stock-music.com Creative Commons Attribution 3.0 Unported License creativecommons.org/licenses/by/3.0/deed.en_US August 2026

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Hanny Al-Samkari and Xin Zhou on their latest articles published in Blood. This episode highlights two important advances in hematology: the first report from the CHORUS registry for hereditary hemorrhagic telangiectasia (HHT) presented by Dr. Al-Samkari and also the introduction of the ASH Hematomics (ASHOP) platform for integrative genomic data analysis presented by Dr. Zhou. The CHORUS registry reveals that HHT is a progressive, underrecognized inherited bleeding disorder with a substantial burden of recurrent bleeding, iron deficiency, arteriovenous malformations, and life-threatening complications, while emphasizing the need for earlier diagnosis and the development of targeted therapies. The second presentation introduces ASHOP, an open-access platform that enables researchers to explore and integrate large-scale clinical and genomic datasets, facilitating discoveries in leukemia and other hematologic diseases through advanced analytical tools. Together, these studies demonstrate how comprehensive patient registries and innovative data-sharing resources are advancing precision medicine, improving disease understanding, and accelerating future research across hematology.

In this Unfiltered episode of Fixing Healthcare, Drs. Robert Pearl and Jonathan Fisher explore what medicine can learn from positive psychology, elite sports teams and the daily pressures facing clinicians, leaders and patients. The conversation begins with Fisher's recent trip to Ireland, where he spoke at a conference on positive psychology, organizational well-being and leadership. Fisher explains that positive psychology is not simply about optimism or self-help. At its best, the field asks a more useful question: What can we learn from people, teams and organizations that are already flourishing? That shift applies greatly in healthcare. Fisher argues that physician burnout cannot be solved by treating it only as an individual failure or by focusing only on what's broken. Pearl connects that idea to leadership. In business and medicine, he says, leaders often try to motivate people through fear, urgency and the “burning platform.” But both he and Fisher question whether threat-based leadership can produce the creativity, teamwork and judgment healthcare needs. Fisher points to research showing that when people feel threatened, their attention narrows. When they feel supported, curious and connected to a larger purpose, they can see more possibilities and make better decisions. The conversation then turns to the World Cup. Pearl uses the tournament as a metaphor for medical practice, asking whether some doctors, like great athletes, are simply better performers than others. Fisher says yes, although the answer depends on what is being measured. Technical excellence matters, but so do teamwork, emotional regulation, communication and the experience of patients and colleagues. That leads to one of the episode's most important questions: What should healthcare do with brilliant clinicians who deliver exceptional technical results but damage the teams around them? Fisher argues that leaders must widen the definition of performance. Safety and volume matter, but so do turnover, culture, communication and the psychological impact one physician has on the rest of the team. A doctor can care deeply about patients and still harm the people required to care for them. The final portion of the conversation returns to medical training. Fisher describes his work with new residents, where he teaches self-awareness, self-regulation, compassion and the ability to reset between difficult patient encounters. Pearl pushes the idea further, arguing that future physicians will also need strategic training: how to lead through others, apply technology, redesign care delivery and help medicine shift from disease reversal to health creation. Cohost Jeremy Corr closes with a patient-centered question that extends the conversation beyond medicine: What should people do when work consumes their lives and leaves no space for health, relationships or meaning? Fisher cautions against simple hacks, arguing that people often need courage, help and boundaries to step off the hamster wheel. Pearl adds that for many Americans, the pace and expectations of modern life have become unsustainable. Strategy, he says, is not only about what people choose to do. It is also about what they are willing not to do. For more unfiltered conversation, listen to the full episode and explore these related resources: ‘Just One Heart' (Jonathan Fisher's newest book) ‘ChatGPT, MD' (Robert Pearl's newest book) Monthly Musings on American Healthcare (Robert Pearl's newsletter) * * * Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple Podcasts or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn. The post FHC #222: From burnout to leadership: how physicians can flourish appeared first on Fixing Healthcare.

Readers leave comments. Readers send emails. Readers respond to your social media posts. But how should you interact with them? The DRS Crew discusses the ground rules.   DRS caffeinates with Larry's Coffee. If you want to purchase fair-trade, organically grown beans that brew into smooth, balanced, never-bitter coffee, visit LarrysCoffee.com/drs, receive a free gift with your purchase, and help support The Dead Robots' Society. Our links: Paul's store: https://payhip.com/paulecooley Paul's site:  https://shadowpublications.com Terry's site: https://www.terrymixon.com/ Veronica: http://www.voicesbyveronica.com/ DRS Discord: https://discord.gg/pgmQxaVbGP Enjoy the show? Consider becoming a Patreon or Buy Me A Coffee supporter and for as little as $1 a month, you can help keep the podcast free and receive exclusive content. More information at https://patreon.com/drspodcast  and https://buymeacoffee.com/drspodcast. #writing #fiction #podcast #chat #live #novel #story #narrative #publishing #author #writer #discussion #podcast #talkshow  

Drs. Chang and Cohen discuss how MRD has become an important tool for assessing how well patients with CLL respond to treatment, beyond what standard blood tests can show. They conclude that although MRD is very useful in research and can help inform conversations with patients, it is not yet clear how or whether it should routinely guide real-world treatment decisions.

When does normal aging end and something more concerning begins? In this episode Shoshana invites neurologist Drs. Ayesha and Dean Sherzai to discuss their studies on Alzheimer's and Dementia. They debunk myths around Alzheimer, discuss what a brain-healthy way of eating looks like, and share why good sleep hygiene is more crucial for brain health than you think. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Drs. Katie Larson and Sherri Gard joined us to discuss how they became involved in organized veterinary medicine. Through her work with the Virginia VMA, Dr. Gard has had the opportunity to influence state legislation. Dr. Larson has served on the Horses at Risk working group for The Foundation for the Horse, as well as vice president and president of the New Hampshire VMA.The Business of Practice podcast is brought to you by CareCredit.This information is shared solely for your convenience. You are urged to consult with your individual advisors with respect to any information presented.Business of Practice Podcast Hosts, Guests, and Links Episode 144:Hosts: Dr. Amy Grice and Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (csisson@equinenetwork.com) | Connect with Carly on LinkedInGuests: Drs. Katie Larson and Sherri GardPodcast Website: The Business of Practice

Host Dr. Joe Patterson chats with JOT paper authors Drs. Stephen Becher and Austin Wynne as they go behind the text of this article entitled: "Knee hemarthrosis aspiration and its effect on compartment pressures in tibial plateau fractures." Click here for the abstract link For additional educational resources visit OTA.org  

This episode explores the realities of private versus corporate veterinary practice through candid stories from experienced vets, highlighting the tradeoffs around ownership, culture, leadership, and career fulfillment. It offers practical insight for anyone weighing a practice transition or trying to make smarter decisions about their future. Join podcast hosts Drs. Jessica Dunbar and Travis Boston as they compare private and corporate practice with Drs. Meghan Delp and Rachael Levine.   Sponsored by: AAEP Practice Life is sponsored by Boehringer Ingelheim. Visit them at https://bi-animalhealth.com/equine/   

Na nga def? Today, travel medicine specialists Drs. Paul Pottinger & Chris Sanford answer your questions about the role of the human gut microbiome in travel health and safety, including:What is the gut microbiome?What is the impact of travelers diarrhea and antibiotics on the microbiome?How can travelers maintain a healthy gut microbiome?What are probiotics, and are they helpful?What about fecal microbiota transplantation?What do we really know about how the gut microbiome impacts our wellness including mood?If I DO need to take antibiotics for traveler's diarrhea, what drug and dose is least bad?We hope you enjoy this podcast! If so, please follow us on the socials @germ.and.worm, subscribe to our RSS feed and share with your friends! We would so appreciate your rating and review to help us grow our audience. And, please visit our website: germandworm.com where you can find all our content and send us your questions and travel health anecdotes. Or, just send us an email: germandworm@gmail.com.Our Disclaimer: The Germ and Worm Podcast is designed to inform, inspire, and entertain. However, this podcast does NOT establish a doctor-patient relationship, and it should NOT replace your conversation with a qualified healthcare professional. Please see one before your next adventure. The opinions in this podcast are Dr. Sanford's & Dr. Pottinger's alone, and do not necessarily represent the opinions of the University of Washington or UW Medicine.

BB28 Sunday Nominations Ep Recap, Week 2 Also available on YouTube. Big Brother 28's alliances get pushed to the edge as chaos strikes after the latest HoH shakes up the game. Rob Cesternino, Taran Armstrong, David Bloomberg, and AJ Norris team up for a Sunday recap packed with strategy talk and messy house moments. Rick Devens wins HoH and, true to his Survivor roots, isn't content to play it safe. With back-channeling and fiery DRs, the panel goes deep on Devens' flashy nominations: Melody, Lyric, and Jason end up on the block, sending house loyalties scrambling. Angela's influence comes into focus—AJ thinks her manipulation steers Devens' HoH move, making messy, fun TV but also suiting his game. The group debates whether Melody’s “betrayal” in the HoH pairs comp really put her on the block, calling out a key production reshoot missing from the episode edit. Rome's misstep in naming too many allies to Devens becomes a lesson in bad negotiation. Meanwhile, Angela relishes her “showman” reputation, as her alliance gobbles up power and DR camera time, all while sporting the classic egg costume after winning the BB Time Capsule twist. AJ spotlights Angela’s clever handling of Rick Devens, speculating her persuasion shapes the “big move” nominations. Taran explains how Melody's switch in the HoH partner comp, due to a production reshoot, directly affects Devens' nominations—though the TV edit skips this. David breaks down Rome's negotiation blunder, noting you should never name your full alliance to an HoH. The group debates if Haley or Devens threw the final comp round, dissecting how throws and optics can reshape house perception. Jason's reaction to not winning the BB Time Capsule sparks laughs, with Taran suggesting his self-pity is extra performative. With the house lines drawn and finger-pointing on the rise, power seems fragile, Angela, Rick Devens, and Dee hold sway, but are lines about to shift again? Will Rick's chaotic HoH pay off, or did Angela's push for drama set up more trouble ahead? Catch the full episode for every alliance shake-up, messy DR moment, and insight into what could happen next in the Big Brother 28 house! 00:00 Episode Kickoff and Nominations 06:57 Rick Devens' HOH and Big Brother Power 14:38 Angela Murray's Bold Big Brother Moves 20:49 Melody's Competition Switch and Fallout 33:29 Devens, Rome, and Alliance Cracks 39:13 Angela and the Egg Costume Reveal 45:15 BB Time Capsule Power and Popularity 53:44 Nomination Ceremony Ignites House Drama 01:01:25 Jason, Angela, and Big Brother Showdown 01:10:09 Rick Devens Wins Veto Showdown 01:21:12 Power Shifts and Alliance Fractures Never miss a minute of RHAP's extensive Big Brother coverage! LISTEN: Subscribe to the Big Brother podcast feed WATCH:  Watch and subscribe to the podcast on YouTube SUPPORT:  Become a RHAP Patron for bonus content, access to Facebook and Discord groups plus more great perks!

BB28 Sunday Nominations Ep Recap, Week 2 Also available on YouTube. Big Brother 28's alliances get pushed to the edge as chaos strikes after the latest HoH shakes up the game. Rob Cesternino, Taran Armstrong, David Bloomberg, and AJ Norris team up for a Sunday recap packed with strategy talk and messy house moments. Rick Devens wins HoH and, true to his Survivor roots, isn't content to play it safe. With back-channeling and fiery DRs, the panel goes deep on Devens' flashy nominations: Melody, Lyric, and Jason end up on the block, sending house loyalties scrambling. Angela's influence comes into focus—AJ thinks her manipulation steers Devens' HoH move, making messy, fun TV but also suiting his game. The group debates whether Melody’s “betrayal” in the HoH pairs comp really put her on the block, calling out a key production reshoot missing from the episode edit. Rome's misstep in naming too many allies to Devens becomes a lesson in bad negotiation. Meanwhile, Angela relishes her “showman” reputation, as her alliance gobbles up power and DR camera time, all while sporting the classic egg costume after winning the BB Time Capsule twist. AJ spotlights Angela’s clever handling of Rick Devens, speculating her persuasion shapes the “big move” nominations. Taran explains how Melody's switch in the HoH partner comp, due to a production reshoot, directly affects Devens' nominations—though the TV edit skips this. David breaks down Rome's negotiation blunder, noting you should never name your full alliance to an HoH. The group debates if Haley or Devens threw the final comp round, dissecting how throws and optics can reshape house perception. Jason's reaction to not winning the BB Time Capsule sparks laughs, with Taran suggesting his self-pity is extra performative. With the house lines drawn and finger-pointing on the rise, power seems fragile, Angela, Rick Devens, and Dee hold sway, but are lines about to shift again? Will Rick's chaotic HoH pay off, or did Angela's push for drama set up more trouble ahead? Catch the full episode for every alliance shake-up, messy DR moment, and insight into what could happen next in the Big Brother 28 house! 00:00 Episode Kickoff and Nominations 06:57 Rick Devens' HOH and Big Brother Power 14:38 Angela Murray's Bold Big Brother Moves 20:49 Melody's Competition Switch and Fallout 33:29 Devens, Rome, and Alliance Cracks 39:13 Angela and the Egg Costume Reveal 45:15 BB Time Capsule Power and Popularity 53:44 Nomination Ceremony Ignites House Drama 01:01:25 Jason, Angela, and Big Brother Showdown 01:10:09 Rick Devens Wins Veto Showdown 01:21:12 Power Shifts and Alliance Fractures Never miss a minute of RHAP's extensive Big Brother coverage! LISTEN: Subscribe to the Big Brother podcast feed WATCH:  Watch and subscribe to the podcast on YouTube SUPPORT:  Become a RHAP Patron for bonus content, access to Facebook and Discord groups plus more great perks!

Artificial Intelligence is buzzy. There's a lot about it in the news and a lot we think we understand about how to use it and a lot we may not fully understand. But the promise it holds is tremendous, and today we're going to learn a little more about how it could benefit breast cancer research and patient care in the near future. Drs. Charles Perou at UNC Chapel Hill and Erika Crosby at Duke University are two very accomplished breast cancer researchers who are joining us today to share their perspectives on using AI now and in the future. Key takeaways AI is improving breast cancer screening and diagnosis. Researchers are using AI to save time on coding, writing, and data analysis. AI can help match patients to clinical trials more effectively. Human expertise is still needed to verify AI-generated results. AI has the potential to accelerate research and improve patient care. Chapters 00:00 — Introduction to AI in Breast Cancer Research 02:53 — Ethical Considerations and Responsible AI Use 04:33 — Current Clinical Applications of AI 08:12 — How Researchers Are Using AI in the Lab 11:17 — AI Limitations, Mistakes, and Critical Thinking 17:23 — The Future of AI-Assisted Cancer Research Learn more at realpink.komen.org and komen.org Real Pink, by Susan G. Komen, shares real stories and expert insights to support people navigating breast cancer, from diagnosis through survivorship.

Recorded live from the American Orthopaedic Society for Sports Medicine (AOSSM) Annual Meeting in Seattle, Dr. Aaron Krych joins Drs. Catherine Logan and Ashley Bassett for an in-depth discussion on the rapidly evolving field of cartilage restoration. The conversation explores how treatment has shifted from simply filling cartilage defects to restoring the entire knee joint through comprehensive patient evaluation, biologic innovations, and advanced surgical techniques.The Evolution of Cartilage RestorationWhy focal cartilage defects should be viewed as a "whole joint disease"Moving beyond isolated microfractureThe growing importance of correcting alignment, instability, and meniscal deficiencyEarlier intervention in young athletic patients to preserve long-term joint healthUnderstanding Natural HistoryWhy untreated cartilage defects can enlarge over timeRisk factors for lesion progression and development of secondary cartilage injuriesCounseling patients on long-term consequences and timing of interventionModern Treatment AlgorithmsWhy strict size-based algorithms are becoming less relevantPatient-specific factors influencing procedure selection:AgeActivity levelDefect size and locationSubchondral bone involvementPrevious surgeryOverall joint healthDiagnostic EvaluationThe expanding role of advanced MRIWhen diagnostic arthroscopy remains essentialEmerging applications of nano-arthroscopy for:Preoperative lesion evaluationAssessment of graft incorporationEvaluation of persistent postoperative symptomsSingle-Stage Cartilage Restoration TechniquesAutoCartSingle-stage autologous cartilage restorationSurgical technique pearlsCartilage harvest using GraftNet technologyPRP/BMAC augmentationTechnical considerations for successful implantationOsteochondral OptionsWhen bone involvement changes the treatment strategyIndications for:Osteochondral Autograft Transfer (OATS)Fresh Osteochondral Allograft TransplantationChoosing between autograft and allograft techniquesAlignment MattersWhy cartilage restoration cannot succeed in an overloaded compartmentIndications for combining osteotomy with cartilage restorationMedial high tibial osteotomy (HTO)Distal femoral osteotomy (DFO)Benefits of patient-specific instrumentation for osteotomy planning and executionLessons LearnedDr. Krych shares valuable experience on why successful cartilage restoration depends on more than the graft itself.Key factors influencing outcomes include:Proper patient selectionMechanical alignmentKnee stabilityMeniscal integrityPatient commitment to rehabilitationKey TakeawaysCartilage restoration has evolved from treating isolated defects to preserving the entire joint.Modern decision-making is individualized rather than based solely on defect size.Addressing alignment, instability, and meniscal deficiency is often just as important as restoring cartilage.Biologic augmentation and single-stage procedures continue to expand treatment options.Successful outcomes rely on appropriate patient selection and meticulous surgical technique.Featured GuestDr. Aaron Krych is an orthopedic sports medicine surgeon at Mayo Clinic specializing in cartilage restoration, complex knee preservation, ligament reconstruction, and sports-related injuries. His clinical expertise and research have helped shape many of today's modern cartilage restoration strategies.Subscribe to The Sports Docs Podcast for conversations with leaders in orthopedic sports medicine, surgery, injury prevention, rehabilitation, and athlete performance.www.cloganmd.comhttps://orthopedicnj.com/physicians/ashley-bassett

Thank you for joining ACOEM for another episode of OccPod. In this timely conversation, host Dr. Ismail Nabeel is joined by Dr. Dominik Dabrowski to discuss substance use disorder in the workplace. Dr. Nabeel is a Professor in the Department of Environmental Medicine and the Department of Artificial Intelligence and Human Health at the Icahn School of Medicine at Mount Sinai.Dr. Dabrowski is the Medical Director at the Naval Nuclear Laboratory, with a background in both occupational and addiction medicine — he completed his occupational medicine residency at HealthPartners and an addiction medicine fellowship at Rutgers University Behavioral Health Care, and most recently served as an attending physician at Mount Sinai Health System.In this episode, Drs. Nabeel and Dabrowski discuss emerging synthetic opioids – including fentanyl analogs, xylazine, and Medetomidine – and what occupational medicine physicians, MROs, and DOT providers need to know about detection, treatment, and the evolving landscape of substance use in the workplace.

Join Dr. Brooke Trainer as she goes behind the scenes with anesthesiologists and social media influencers, Drs. Max Feinstein and Zain Hasan, to learn how their journeys began, how their audiences have evolved, what they hope to convey with their content, and more. Recorded June 2026.

As a nurse with MS, I’m interviewed about AI’s real role in care: pattern recognition, human-in-the-loop skepticism, and the Three T’s and Two C’s framework. Click here to view the printable newsletter. More readable than a transcript. Click here for a verbatim transcript Summary I sit in the guest chair on Practical AI in Healthcare with Steve Labkoff. I walk through my experience feeding my own symptom logs, lab results, and ten years of clinician notes into an AI LLM: a physical therapy referral I needed and hadn’t scheduled, a medication side effect my neurologist later confirmed, and a rating scale buried in my chart that no one had surfaced. I describe the less impressive side: the four-pound box of unsorted paper my primary care practice mailed me and the 296 pages of unsearchable PDFs I got back from another system in fifteen minutes. Along the way, I lay out my framework for judging any digital health tool, the Three T’s and Two C’s: time, trust, talk, control, and connection, and explain why I insist on keeping humans in the loop even though the research on that is more complicated than people assume. This isn’t a pitch for AI in healthcare. It’s a working nurse and patient’s honest field report. What’s your experience been feeding your own health data into an AI LLM? Tell us in the comments. Episode Transcript Proem I usually ask the questions. This time I'm the guest. I met Drs. Steve Labkoff and Leon Rozenblit a couple of years ago at a DCI Network conference. They host Practical AI in Healthcare, a show I've listened to steadily, though it creates more tension for me than any other podcast I keep coming back to. Usually, I jettison podcasts that do that. I stay with this one because I approach AI in healthcare the way I approach best health; I'm an N of one and resist generalizing, while most guests do a fair amount of it. I bristle at most of them, wanting the shades of gray that reflect deep understanding. In four of 33 episodes, the guest has had lived experience: ePatient Dave DeBronkart, Amy Price, Hugo Campos, and me. I invited Steve and Leon to join my virtual Reckoning group, which I've hosted since 2019. We give podcasters warm critiques of selected episodes: the kind of feedback you give when you've made a hundred mistakes yourself, can spot them quickly in someone else's cut, and have endless thoughts about production, audience, dissemination, and life. They took the critique well. When Steve later asked me to come on his show to talk about how I use AI, not the theory but the daily grind, I readily agreed. They let me publish it here unchanged, apart from this Proem and Reflection. I struggled to prepare for this conversation. I wanted to wear all my hats, but had to narrow my focus to two. I chose my lived experience and nurse hats. Underneath it all was the question I keep circling back to. Not a cure. Best health, the most function, and Hello, and welcome to this week’s edition of Practical AI in Healthcare. My name is Dr. Steven Lapcoff, and this week I’m actually on my own because my partner, Dr. Leon Rosenblatt, is actually on spring break with his kids, so I am covering for him and he’ll be back in the next week. This week we have a guest who we met at a conference in Boston a few months ago at the Beth Israel at the DCI network. Steven Labkoff: We have Danny van Leeuwen. Danny is a nurse. He has background in giving actual physical care to patients. He actually runs his own podcast called Health Hats, the Podcast, and he’s been using AI in both his personal life and in his professional life very extensively. Also, Danny has a significant medical condition, and I’ll let him explain that in the course of the discussion because it’s with that lens that we got introduced at our patient-centric AI conference, and that’s why we thought it’d be a good idea to have Danny come and have a chat with us. So welcome to the podcast, Danny. How are you today? Health Hats: I’m good. Thank you. Thanks for having me. I appreciate it. Steven Labkoff: So Danny, as you probably have heard because you’ve helped us with our podcast, and for that I want to say thank you. For those who are listening in, Danny runs actually a group that actually helps folks running podcasts improve their podcasts, and he’s had Leon and I on many times to listen to critiques and feedback, and it’s been very, very helpful. Danny, we often start our podcast with asking for folks’ origin stories, like how did they get their cape and their superhero tights. What did you do to get you to this point in your life? And just tell us the background of what brought you here. Health Hats: Oh, thanks. So I’m a child of Holocaust survivors, and my parents– when I was young, my parents were active in the civil rights and fair housing movement in the ’60s. And when I was 16 and I was thinking about the war in Vietnam and worried about getting drafted, I wanted to learn what I could learn about the draft and how I could protect myself and manage. And I went to a church in downtown Detroit, and I went for a session of draft counseling as, you know, a little precocious at 16, and I found it fascinating, and they found me fascinating, and they encouraged me to become a draft counselor. And so I, uh, I actually took their course and became a draft counselor, and what I learned is that you change systems from the inside, not the outside. And I learned how the sausage was made, and that, uh, really pointed me in a direction. The way I got into nursing is really because I didn’t want to cut my hair I had an opportunity for a job at one point, and I could have read water meters or become an aide at the Detroit Psychiatric Institute. And reading water meters paid more, but I didn’t wanna cut my hair, so I got the job as, as nurse’s aide. And while I was there, they introduced me to the idea of going to nursing school, which was amazing. Steven Labkoff: It was more– You got paid more to read meters, water meters, than you did- Health Hats: Yes. Steven Labkoff: That’s unbelievable. Life gives you some real interesting turns and twists, doesn’t it? Health Hats: It does. And I was really fortunate because my first jobs in nursing were in physical rehabilitation and home care. I just happened to be in a place where the Holyoke Visiting Nurses was dying to hire a guy, and I was a brand-new nurse, and they ended up hiring me. And so my first introduction to nursing was not in acute care. It was in home care, and actually, I was the first male public health nurse in Western Massachusetts in 1976. And really, what I learned there was that most healthcare does not occur in the medical system. It occurs outside the medical system. And so when I ended up getting into medical care, it was always so interesting to me that everybody there thought this is where, you know, health happened, which it doesn’t. So over the 20 years of working as a nurse, I’ve worked in, other than the rehab and home care, I’ve worked in the emergency department, I’ve worked in ICU, I worked in pediatrics, behavioral health. And after about 15, 20 years, I shifted from becoming a student of individual health to a student o- of organizational health. And what I mean by that is I got into performance improvement. I led a couple of electronic health record implementations. I had a couple of gigs in the C-suite. I did some consulting. Now, in 2009, I was diagnosed with multiple sclerosis, and when I was diagnosed, I learned that I had had it for 25 years. And since my father died young, he died at 45 when I was 19 of his second heart attack, and so every time I would have some kind of episode, I would get a cardiac workup. And by the time the cardiac workup was done, you know, the episode was over, and this went on two, three, four times a year for a long time. And there was a pattern there, and nobody was connecting the dots for 25 years. That’s very important to me because the pattern of what was going on was in my records for 25 years, but nobody had synthesized it. Steven Labkoff: Yeah, they may have been biased, right? Because of your family history and having these episodes, you know, as a clinician, you get very biased by family history, and that can actually lead you down roads which may not be correct, and it sounds like that’s precisely what happened with you. Health Hats: So I’ve– I wanna bring in the caregiver role because I have been a caregiver for my grandmother, my mother, and a son in their end-of-life journeys. So I’ve been on many sides of very difficult decisions. As you said, that my shtick is health hats, and I’m health hats because I’m a patient, I’m a caregiver, I’m a nurse, I’m an advocate, I’m an informaticist, I’m a podcast host. I wear a lot of hats. And wearing many hats has gotten me a seat at many tables because they can check off boxes. When it was really different to be bringing patients o-on board, I was an easy choice. Uh, I was at the table for technical expert panels at CMS, at National Academy of Medicine, at AHRQ, National Quality Forum, PCORI, Patient-Centered Outcomes Research Institute. But really, I wasn’t really there in it for the seat itself. My goal was always to open seats for people who weren’t there yet Now let’s build the bridge, since this is a podcast about AI, let’s build that little bit of that bridge. So my first, like, serious experience with– Well, I don’t know about my first. I was involved in something that you probably are familiar with, which was the Blue Button Plus program, and my goal in that, I was there both as a patient and as somebody who was working with people with disabilities. I, I was VP of quality for an organization that supported about 40,000 people with disabilities. And my goal for that couple of years of weekly or every other week, I can’t remember, calls was, uh, to add a f- a caregiver field to the data set, and to also introduce the idea that what people needed was information that would be able to say what works for me when I’m in pain and what works for me when I’m afraid, which was an issue for me, and it was an issue for the organization that I was working with at the time. Now, I have to say that the caregiver field got added, so I felt some success in that. But as a nurse leader in the informatics group I was part of, really they were only interested in putting a name in the field, not doing anything with that information, which I- Just collecting, so just collecting the data. Steven Labkoff: They didn’t care what the data was used for? Is that what you’re saying? Health Hats: Correct. Yeah. And I couldn’t– got no traction on the pain and fear, which now that I’m older, I understand why, how difficult that is. Nevertheless, it’s something that’s important to patients and caregivers. So I think I would close this section with that I am both an early adopter of technology and a rapid skeptic, that I’m kinda making this number up, but I’ve probably tried over 100 health apps, and I would say that I’ve used five more than three times. And so I think there’s a gap between what’s promised with digital technology and what’s useful for people. So that’s really why I’m here and what’s guiding for me in this. Steven Labkoff: So let’s take it to the next step. In our prequel, I didn’t even know about your personal background to that degree. Mm-hmm. We can take that one offline later about the Holocaust survivor issues. We, we have family, I have family in that same situation, frankly. Let’s change gears and talk about the challenges that you’ve seen. You opened the door a little bit on that a few minutes ago- Yeah … in terms of people wanting to collect data but not necessarily doing much with the data, not being able to understand the true value of the data to some degree. And you said it yourself, people weren’t connecting the dots. Medical records have always been complicated. They’ve always been bulky. They’ve always been full of information, some of which is really relevant, a lot of which is not so relevant, and connecting the dots to making that a, uh, an important information source is not always an obvious task. So what, what was the particular angle on that challenge that you were trying to gun at? Health Hats: Well, I think we have to take a step back- and think about what is– Well, I’m just gonna speak for myself, okay? I know that I often, you know, as I said, I get asked to sit at the table because people can, you know, check boxes, like is that I’m a patient. I wanna be clear that I’m a privileged white old man with MS living in Boston, but I’m an N of one, and I don’t represent other patients. I’m representing myself here and my perspectives. My goal in terms of my health is best health, and what I mean by best health is optimal health and function, physical, mental, spiritual. Not a cure, but best health for where I am, what I have right now. And to get there, I need my own health data, not just what’s in my clinician’s chart, but what I know about myself, my circumstances, my environment, my history, my habits. Not just my medical history, my life history, my treatment responses. And so that’s like patient-reported data, and that’s stuff that’s only exists because I observe it and sometimes I record it And that’s where it falls apart right away. You were just alluding to some of it, that there’s all this medical data and what’s useful about that. I think Dave DeBronkart was a guest on your show. And when he launched his Gimme My Damn Data campaign, I responded to him with, “Watch what you wish for. You’ll be trying to drink dirty water from a fire hose.” And, and that was years ago, and it’s still true. So six months ago, I, I’d been on a mission to gather my medical data, and my– I’d been with my, uh, primary care practice since 2011, and I wanted all that data from 2011 to 2025. This was, like, in December I started on this crusade of trying to get my data. And actually, two months later, I got a box, a four-pound box of paper, and it was paper that was not in chronological order. And it’s just sitting right here. I’ve scanned it in. It’s not, um- Was it in– Steven Labkoff: Was it a printout of Epic or something, or was it actual- Health Hats: It’s a computer printout. It seems like it’s a vendor that they use to- Steven Labkoff: It wasn’t digital. They sent you, literally sent you a box of paper. Health Hats: Yeah, it was a box of paper. Oh. And then I use a lot the, the Beth Israel Lahey Mount Auburn system, and I asked for the last three months of my records, and I got 296 pages of redundant, non-searchable PDFs, and I got that in 15 minutes. Uh, I see a lot of doctors, so maybe I had seen Hmm. I think I had maybe eight or nine visits, and it just happened to be a three-month period that was busy for me, but I got s- 296 pages. And so that really adds to your comment, which is that access to data and access to usable data are really different. Steven Labkoff: Oh, absolutely. And yeah, I’ll tell you, in my world, I think you know that I’ve worked in the life sciences for many, many years, and we are consumers of healthcare data on many levels. We consume medical claims, we consume electronic medical records, and one of the hardest things about using medical records for research or for outcome studies and things like that is the very fact you’re describing, which is the data tends to be sparse, it tends to be poorly organized. It doesn’t always come in an encoded fashion. Thank God most of what we get these days is at least digital. No boxes of paper for us these days, but it wasn’t so long ago that when it was all paper, we couldn’t get that data in the first place. It just wasn’t even gettable. So at least you’ve made some progress. And- Yeah … yeah, I know that you sit on some national level boards, uh, around outcomes, and you can talk about that in a moment. But those are, you know, those boards are trying very hard to come up with outcome studies and ways of– Let me back that up. They’re coming up with ways of using data to perform outcome studies by harmonizing and, and distilling down to usable forms of this EHR data, which is so challenging. Health Hats: I think what’s key, I– like I, I think I w- I’d like to focus on my data. And so what I wanna do is I wanna see patterns. I wanna see patterns that takes my circumstances, my environment, my habits, my treatment over time, and because I think that these patterns are how I formulate the right questions, so the right questions before I go into a clinical encounter. They’re how I track when something is actually working, and it helps me to coordinate across care teams that don’t talk to each other and make decisions that I can live with that help me attain this goal of best health. So that’s the job, formulate better questions, g- seek better answers, make better decisions. And AI is the tool that I try to use to do it. Now, whether it’s up to the task or not is different. I wanna stick in the nursing angle, if you don’t mind- You know, one of the things that I learned the way I got started in nursing is that my goal as a nurse was to put myself out of a job. Steven Labkoff: So that sounds counterintuitive, but what I mean is from minute one with a patient and family, I’m planning my exit. Like, and to do that, I need maximum face time. I need real present, real conversation, real relationships, not less charting. I was gonna say not charting, not documentation, so that’s just ridiculous. Health Hats: But less, you know. The way you do that, I think, is, you know, less charting, less documentation, you know, not hunting through information you can’t find. And that’s where nursing, that’s a genuine promise. So pattern recognition across specific cohorts of patients. So as a nurse, even though I worked a lot of different places, in each place I worked, there was commonalities. In– When I lived in West Virginia and I was an ER nurse in a super rural hospital, if I had had more information about my patients, their families, I could get– an AI could help me surface those patterns that exist for the people that I’m taking care of, I think I could get time back as a nurse. And if the nurse gets time back, then the patient and family gets the presence of the clinician. So that’s the trade that I’m interested in I wanna go back to that thing about pain and fear. I wanna add what I’ve learned working on the blue button, plus I wanna add cognition. So when you think about it, the data almost never captures the variability of pain, fear, and cognition, and those things are really important because pain changes what you can do and what you can decide. Fear closes your heart. It closes your mind. And so when you’re scared in a clinical encounter, you’re not making good decisions. You’re just saying yes to end it. And cognition is, you know, it varies. Like I can absorb better at 10 in the morning on a good day compared to 3:00 in the afternoon when I’m spent. You know, you could extrapolate this to other people. They have their own particular patterns and circumstances. But I think What I’m trying to get at in all of this is it isn’t first about the data, it’s first about what about life and what about the things that are important to people, uh, patients, caregivers, and the clinicians that they partner with, and how can AI help them? Steven Labkoff: So you’ve explained to me in the pre-call that you’re doing some of this work, so maybe you can unpack a little bit about what it is you’re actually doing with it and how it’s helping or, in some cases, not helping those efforts. Health Hats: Well, what have I done? I, I’ve done different things. One of the things that, that I’ve done is to try to build my toolkit. You know? So when I say build my toolkit, I’m a, I’m a, a conglomeration of symptoms. I mean, you know, I’m, I’m not MS, I’m not my symptoms, but they’re big and they’re there, and I feel like I’m trying to, I’m trying to figure out for anything that I have to deal with, whether it’s any of the different kinds of pains I have, my, my anxiety, my bladder, you know, my mobility, I have challenges, and I, I need a toolbox. I need a toolbox, and the way I think is I need at least three things that will work so that when they happen, I got something I can go do, and pretty much the most common thing is drink water. Drink water is by far the most successful intervention across all of my symptoms. It’s kind of amazing. It’s so cheap, so easy. It isn’t the drugs. Okay, but so how do I do that? Well, for me, I’ve done that partially just in my head. Partially I’ve done that by keeping lists. Like, I keep track of the steps I take. I keep track of the amount of time I play music. I keep track of my falls. I keep track of my weight. And so I use digital tools to do that when I can. Steven Labkoff: I also record my clinician visits because- When you say record, do you mean like audio record or dig- Health Hats: Yeah. Yeah, audio record, right. And, uh, until recently I used Abridge, which is a company that, um- Steven Labkoff: How did you get to use Abridge? You– I thought Abridge was only selling basically into doctor’s offices, uh, from the clinician side. Do you- Health Hats: So I was before that. Ah. And they started as a patient-facing product, and actually they sponsored my podcast for three years. So I was pre that. So putting all that together, so I play with, you know, trying to put into Claude There’s nothing magic or special. You know, it’s me playing, just trying stuff. You know, some of it, you know, my wife will say, “Hey,” she sees a pattern. My kids will see a pattern, or I’ll- Steven Labkoff: Give, give, give us an example of what, of what this looks like. I mean, you’re saying you’re giving Claude or another LLM- Yeah … a series of symptoms, or you’re giving it a series of, plus your data. Like, unpack it and let us know. Yeah. What have you did- Okay, so what- … with the system, and how is it working for you? Health Hats: I’ve done a couple of different things. One is, you know, I have a spreadsheet, and I just put the spreadsheet in, you know, as a document or whatever you call it when you have a project and, you know, you load. I load my spreadsheet. I keep a annual summary, and I keep the year that I’m working on. And I will have fits of journaling. You know, I, this is not something that I am, like, super consistent on, but I’ll, especially when I’m struggling with something, if I’m struggling with my blood pressure or I’m struggling with my mood. I have a progressive mobility thing going on, and I’ll put that in and I’ll prompt. I’ll say, “Can you– do you see a pattern in this?” You know, and I’ve gotten, you know, that there’s- Steven Labkoff: Has it given you some insights? Is it… Like, give me an example of some of the insights it’s actually given you that you didn’t see yourself. Health Hats: Well, I’ve gotten, like, uh, it’s kind of humorous. But, but I’ve gotten, like, you know, “Have you thought about seeing a physical therapist?” And I, I have. You know, I have a physical therapist, uh, that I don’t go to very often. You know, my relationship with her is I go for a tune-up. But they’ll– I, I want– It’ll show, like, I’ll do my sort of things are clearly, you know, I’m not walking as far, I’ve fell on a few times, you know, and I’ll get this suggestion, you know. I also– What else have I done? Oh, oh, uh, once I had a medication that I was taking for neuropathy, and I was– my mood had, like, changed considerably and, you know, I got a thing on that might be a side effect. You know, “Have you talked to your doctor about this?” Steven Labkoff: And I- And you got that out of the LLM? You fed that to the LLM? Health Hats: I did. Yeah. Steven Labkoff: And it suggested it was a side effect, which you didn’t figure out. Health Hats: I didn’t. A neurologist said that he thought– He said, “It sounds like you have an allergy to it.” And, you know, he wanted it to be listed as an allergy because he thought it was very possible that he’s had people that have had a problem. Steven Labkoff: When you tell me that you’ve loaded your data, you give the LLM your signs, your symptoms, you give it your labs, you give it what’s in, in the system, and it comes up with a recommendation that you hadn’t thought– Now, you’re a clinician. You’re a nurse. Yeah. You’ve been a nurse for many, many decades. Health Hats: 50 years. Steven Labkoff: 50 years. And does it surprise you that it comes up with stuff that you didn’t see? Health Hats: No. Steven Labkoff: Cause I, to be honest with you- I- … if I, if I did what you just said and it came up with something completely radical that I’d never thought of and it was right- I would be scratching my head and thinking, “Okay, that’s in- that’s beyond interesting. I better pay more attention to this, and maybe I wanna use it differently.” Because not, it’s not just yous using it. Like, people around everywhere are starting to use it for the same, in the same sim- in the same exact way. So that’s the simplification of the medical system, right? Health Hats: It does. I mean, like when I tell my neurologist, he laughs, and he’s like a whatever works kinda guy, you know? That he feels like he doesn’t have all the answers, and that he likes- those stories. I feel like I’ve learned, I think you know Amy Price, right? Steven Labkoff: Yeah, very well. Health Hats: Yeah. We’re buddies. And so one of the things that I’ve learned from her is how to query and how to be skeptical and how to ask questions from different angles, from different perspectives so that you– And that’s why I think that’s where the unexpected comes up. Steven Labkoff: Well, you’re describing something that we did at the conference. I don’t know if you were in the room in the working group that we did this on, but you’re describing, and actually we’re submitting a paper on it very shortly, on AI literacy. Yeah. And you, you didn’t label it as such, but you’re describing yourself as being AI literate and understanding how to use the tools, most importantly, how to be skeptical of the answers, how to interpret the information that’s being presented to you. Health Hats: A- and that, those are all components of literacy, of AI literacy specifically. One of the things I’m finding in my world is that painfully few people are indeed AI literate. Even the folks in IT departments in large life science companies or hospitals who even work in the space and think that they’re good at it and are literate sometimes are not. That has other implications, which are if people are taking on these really impressively powerful tools and they don’t quite know how to use them as well as they should, and if they query them incorrectly, to your point earlier about making good queries, the responses that come out may or may not be the point. And if patients use that information inappropriately because they didn’t know how to ask the right questions to start with, that could have deep implications to the healthcare system. You could say that same thing about doctors. Steven Labkoff: I will say it about doctors. I mean, not about AI, about the advice that doctors give. Health Hats: There’s a, a tremendous variation, and it is very different. When I am feeling good enough to be organized and to be directive in the conversation with a clinician, I get a very different output than when I’m not. And I still have to be skeptical of what doctors tell me, and until I build some trust. And, and then I, you know, then there’s just too many decisions to make when you’re a person with chronic illness. It’s like putting in a kitchen. There’s so many decisions to make, and I’m happy for the doctors that I trust to make the decisions for me. But there are certain decisions I don’t want to give to the doctor or to AI, like I don’t wanna mess with my pathological optimism. I wanna progress as slowly as possible, and I wanna keep playing my horn. These are really important things to me, and I don’t give those decisions that affect that, I don’t give up. But all the rest of it I do, and, and I’ve worked really hard to build the team that I have that appreciates me and my strangeness and my assertiveness, and, you know, they’re not threatened by it. Steven Labkoff: Is your team AI literate? Do they also use the, these same tools in your care? Health Hats: Uh, like I don’t know. I mean, AI literate is like, is huge. You know? I mean, that’s just such a big thing. Do they use AI? Yes. Do I know how they use AI? Well, you know, they use what’s attached to Epic. I know that. Uh, I mean, look, my neurologist, who I just love, he thinks like he uses, he uses the portal well because he takes– he just keeps adding things to the end of the, a note. Yeah. And so he feels like… Well, I don’t find his notes at all useful, and I tell him that. I tell him, “What I really wanna know is, how am I doing? Am I getting better? Am I getting worse? Am I stable? What should I be paying attention to in the next six months till I see you again?” And I can’t find that in his note. That’s true. Yeah. Now, on the other hand, I’ve taken his note and asked Claude and say, “Here’s the note. How am I doing? You know, have I progressed? H-how is he measuring it?” Oh, well, then I find he’s using this scale, right? And it’ll come up with looking through this note, which is like 10 years running, and it’ll find, I can’t remember the name of it, but there’s a scale that he uses. And then we go back and I’ll say to him, “Oh, you’re using this scale.” And he goes, “Yeah.” And I say, “Well, why don’t you like put that at the top of your note?” You know, so that I can find it. You know, so we have that kind of conversation- Yeah … that AI has helped. Steven Labkoff: Well, that’s actually an interesting perspective that AI is helping to reorganize things, ’cause one of the use cases that has been discussed at, at length actually, and it was discussed at our conference, is using AI to digest medical records. Health Hats: And when I say digest, it’s not about like ingesting them, which is slightly different, but digesting, which means find all the different pieces, put them together, come up with a narrative that summarizes perhaps 300 pages of information which may be sparse and may be poorly organized, and bring it all together. And that’s actually a task that AI is actually turning out to be pretty darn good at. And that again changes the nature of the healthcare system and the healthcare journey. You know- And it does a fair job. You say it’s really good at it. So- It’s better than I could do. It’s better than I could do. Well, yes. Well, you’re not– First of all, that’s not your training, and you don’t have the time for it. And you still have to review it. Yeah, of course. Because I have never used AI that gave me a, “Oh, this is great.” I mean, the first time I read it pretty much every time I think it’s amazing. And then, you know, my rule is sleep on it and check it again. And then it’s like, oh my God, this, first of all, it either just said nothing very fancy or it got some very basic things wrong. And then I’ll say, “Oh, you know, you missed this and you missed that.” And it’ll go, “Oh, you’re right, I did.” You know? Steven Labkoff: Well, that also speaks to the concept of keeping a human in the loop- Yeah which is something that you espouse and many folks in the healthcare aisle- I do … espouse. Ironically, you know Adam Rodman, I think. He was at our conference, he spoke. Yeah. Uh, he’s done a study which shows actually having a human in the loop in some cases actually makes the conclusions worse, believe it or not. Ah. Which is w- a non-intuitive finding. You would think that the two together would be better than either one alone, but so that’s, that’s now relatively n- well, it’s not even that new anymore. That information came out about a year ago. So I, we gotta start wrapping up in a few minutes here. Yeah. You know, we didn’t cover the concept around outcomes around your three T’s and two C’s. Maybe we can cover that in the last bit here, and then we can get to closing. Health Hats: Okay. So I feel like one of the questions that you’ve asked is how AI helped, right? And so what I need to tell you is the framework that I’ve developed over the years, which I’ve actually shared in my AI Claude project that’s Danny’s Health, what I call the three T’s and the two C’s, and this is like the framework I use to evaluate any digital health technology. And so they are time, trust, talk, control, and connection. What I mean by that is time is, you know, you need time to learn, to plan, to talk, to build trust. So I say the clock isn’t the enemy, it’s the, the wrong things filling the time, so the, the time. The second is trust. You know, trust can take a really long time. It can happen really quickly. Sometimes you never have it, and you know in your gut when you don’t have it. And most digital health tools, AI, have a trust deficit, I think, not because they’re untru- untrustworthy, which maybe they are, but it’s really because the people who use them, use the tools, don’t, don’t trust them, and I think it’s really important. You c- you can’t shortcut trust in the use of any tool. I think talk is really important. It’s woven through all of it, real conversation. There is nothing like actual conversation that is making decisions together, which is a lot of what healthcare is about, is making decisions. AI can help you prepare for it, and it can help process it. And then control. I trust more when I have power in a situation. So if I’m feeling like an ant ready to be crushed, I’m not making good decisions. And finally, I would say connection is, it’s the human lifeline. You know, when somebody greets you when you cross a threshold, that’s a connection. When someone’s been where you’re going and they can say, “Oh, that helped me.” AI can extend that connection. They can help people find communities that are available at 3:00 in the morning, but you can’t manufacture it. I, I think that connection is really important, so that’s where I g- you know, time, talk, trust, control, and connection, and I use that framework when I’m evaluating. Steven Labkoff: And that framework gives you a better, you know, a how do I say this right? It gives you a, like a rubric, if you will, to go- Yes … through, uh, the information that’s coming out of it. Danny- Yeah … we’re gonna have to wrap up here in a second. Sure. Are there any last comments you wanna make that, that will, you know, help other patients in the, in the space in terms of how they might wanna think about adopting- an AI tool in their world? Health Hats: I think that I would say use it, use AI, keep using it, experiment with it. That, that i- i- just like anything else, it takes time to learn. It takes time to be comfortable with it. Use it. I would say advocate for humans in the loop. I don’t care what the study says. It’s about humans. We are human. Keep it humans in the loop. I would say find a buddy, you know. Do this with somebody else. Find a buddy- That’s good advice … and experiment. I would say, yeah, talk to your clinician about it. It’s a good barometer of a physician. If they don’t wanna talk or blow you off, that tells you something. Absolutely right. And I would say if you’re comfortable with it, mentor. You know- That’s a good idea … be the buddy. And for clinicians and for systems and developers, I would say you need to have patients, caregivers, and practicing partner clinicians in the design. They need to be there from the beginning. And, you know, so i- it solves the problems people have, not the problems that the developers think are there or the venture capitalists thinks are gonna make money. You know, y- and if you have an opportunity, join, you know, participate. Steven Labkoff: All good advice. Well, Danny, I wanna thank you very much for your participation in, in today’s discussion. Hopefully that there are other patients out there who listen to the podcast, they’ll take something away. For the clinicians out there who are listening, you know, you’ve heard it straight out from a patient who happens to be a healthcare provider himself, and he’s got very strong perspectives on how this can be used in a positive and productive way, and I think the framework that he’s put together is very useful. Danny, I wanna just say thank you for all the help that you’ve provided helping this podcast get off the ground. That’s been really incredibly generous of you and your friends who have helped us a lot, and a lot of the things that have happened on our podcast, uh, for improvement’s sake, have come directly from those conversations, so thank you for that. I wanna thank you for being a guest and sharing your journey and sharing your experiences here. And for the rest of us, I’m gonna say thank you for joining us, and we will see you again next time on another episode of Practical AI in Healthcare. Thank you for listening. Thank you for joining us this week on Practical AI in Healthcare. If you’re ready to go beyond buzzwords and hype and explore how AI is truly transforming healthcare, stay tuned for more conversations that get us to what works. Until next time, stay practical Reflection When Steve interviewed me, he didn't know that everything I told him is the origin story of TrustMyOwn.Health. The box of paper. The 296 pages that were technically my data and practically useless. Twenty-five years of a pattern that sat in my chart the whole time, that it took a person, my PCP, a year to put together. Could AI have done it in an afternoon?  I got tired of that being the normal experience instead of the exception. [Add: what specifically prompted starting TMOH, and when.] TMOH starts from a premise I didn't have language for until I said it out loud to Steve: trust isn't a feature you bolt onto a health platform after the engineering is done. It's the whole structure, or the whole thing fails. The three T's and two C's I use to size up any digital health tool turn out to be close to a design spec. Time, because a vault of your whole health history takes patience to build, not a single import. Trust, built into governance rather than promised in marketing; TMOH's Data Sovereignty Covenant binds the board and investors to the same terms as everyone else, which is the only version of trust I believe in. Talk, because the point was never to replace the conversation with my clinician, it was to walk in more prepared for it. Control, because I decide what goes in the vault and who sees it, the same way I decide which of my own decisions I hand to a doctor or an AI and which ones I keep for myself. Connection, which no vault can manufacture, but a good one can make room for. I told Steve that AI found a pattern in my chart that twenty-five years of clinicians missed. That's not really a story about AI being smart. It's a story about who owned the data long enough to ask the question. That's the whole bet behind TMOH: put the owner at the center, and let the rest of the ecosystem, the networks, the vendors, the AI, earn its place around that. See you around the block. Practical AI in Healthcare Episodes https://open.spotify.com/episode/4wA4ltjmZfIZ5VpmTeTTOF?si=KbEvc2_ERNWakJ3JeP2Ddg https://open.spotify.com/episode/0LDetUFJJrSV1cy6LtpGFx?si=qAqoqKBBSNm9PiwPjSIXYA https://open.spotify.com/episode/0wXEm1KnnGorOvTt9GTh7o?si=K_DKXzGyThusBPA6KoVkCg https://open.spotify.com/episode/6krV94ob6Lcv7VNo0qahZ5?si=B6lZDkvsQ9y2Z2FhkXzQGQ Referenced in episode Patient data access history: “Introducing Blue Button Plus: The Next Generation in PHRs” — HealthIT.gov (Office of the National Coordinator for Health IT) — https://www.healthit.gov/blog/consumer/introducing-blue-button/ The “Gimme My Damn Data” campaign Danny references: “Gimme My Damn Data (and Let Patients Help!): The #GimmeMyDamnData Manifesto” — Dave deBronkart, Journal of Medical Internet Research — https://www.jmir.org/2019/11/e17045/ Amy Price, mentioned as a mentor in questioning and skepticism: “Welcoming Dr. Amy Price as Editor-in-Chief” — Society for Participatory Medicine — https://participatorymedicine.org/2024/welcoming-dr-amy-price-dphil-as-the-editor-in-chief-for-the-journal-of-participatory-medicine/ AI literacy for patients, the concept Steve names in the episode: “Critical AI Health Literacy as Liberation Technology: A New Skill for Patient Empowerment” — National Academy of Medicine — https://nam.edu/perspectives/critical-ai-health-literacy-as-liberation-technology-a-new-skill-for-patient-empowerment/ Human-in-the-loop research Danny and Steve discuss (Adam Rodman): “AI and the Evolution of Medical Thought with Dr. Adam Rodman” — NEJM AI Grand Rounds (podcast) — https://ai-podcast.nejm.org/e/ai-and-the-evolution-of-medical-thought-with-dr-adam-rodman/ Abridge, the ambient AI scribe tool Danny mentions using: “Pioneers in Generative AI for Healthcare” — Abridge — https://www.abridge.com/about The DCI Network conference where Danny met the hosts: “About DCI Network” — DCI Network, Beth Israel Deaconess Medical Center — https://www.dcinetwork.org/about-us Please comment and ask questions: at the comment section at the bottom of the show notes on LinkedIn  via email YouTube channel  DM on Instagram, TikTok to @healthhats Substack Patreon Production Team Kayla Nelson: Web and Social Media Coach, Dissemination, Help Desk  Leon van Leeuwen: editing and site management Oscar van Leeuwen: video editing Julia Higgins: Digital marketing therapy Steve Heatherington: Help Desk and podcast production counseling Joey van Leeuwen, Drummer, Composer, and Arranger, provided the music for the intro, outro, proem, and reflection Claude, Perplexity, Auphonic, Descript, Grammarly, DaVinci Resolve, DaVinci AI Art Generator, OpenArt AI Creator Studio Inspired by and Grateful to: Steve Labkoff, Leon Rosenbilt, Amy Price, Leon and Oscar van Leeuwen, Laura Marcial Artificial Intelligence in Podcast Production Health Hats, the Podcast, utilizes AI tools for production tasks such as editing, transcription, and content suggestions. While AI assists with various aspects, including image creation, most AI suggestions are modified. All creative decisions remain my own, with AI sources referenced as usual. Questions are welcome. Creative Commons Licensing CC BY-NC-SA This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms. CC BY-NC-SA includes the following elements:    BY: credit must be given to the creator.   NC: Only noncommercial uses of the work are permitted.    SA: Adaptations must be shared under the same terms. Please let me know. dannyhealthhats@gmail.com  Material on this site created by others is theirs, and use follows their guidelines. Disclaimer The views and opinions presented in this podcast and publication are solely my responsibility and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute®  (PCORI®), its Board of Governors, or Methodology Committee. Danny van Leeuwen (Health Hats)

SPONSORED BY NURP Nurp is algorithmic trading designed specifically for busy professionals who don't have time to watch markets. Check out start.nurp.com/doctors  to learn more. --- Why are so many patients still struggling with debilitating symptoms years after COVID—and why does conventional medicine seem to have so few answers? In this encore presentation, Drs. Tim and May Hindmarsh sit down with internist and cardiologist Dr. Peter McCullough for an in-depth discussion about long COVID, persistent spike protein, chronic inflammation, and the growing number of patients experiencing symptoms that don't fit neatly into traditional medical models. The conversation explores why some individuals develop lingering neurological, cardiovascular, gastrointestinal, and immune-related symptoms long after infection, the emerging theories surrounding persistent spike protein, and the ongoing debate over diagnostics and treatment approaches. Whether you're a clinician, patient, or simply trying to understand why long COVID remains such a challenging condition, this episode dives into one of the most controversial and widely discussed topics in post-pandemic medicine. Note: This episode is being re-released due to continued listener interest. The discussion reflects the guests' perspectives and the evidence available at the time of recording. Research into COVID-19, long COVID, and related therapies continues to evolve. In This Episode Why long COVID continues to puzzle physicians Symptoms that extend far beyond the respiratory system The connection between inflammation, clotting, and neurological symptoms Current theories surrounding persistent spike protein Why some patients experience dramatically different recoveries Autoimmune responses and chronic immune dysregulation Mast cell activation and histamine intolerance The role of the gut microbiome in recovery Challenges surrounding laboratory testing and diagnosis Why individualized treatment approaches remain essential Emerging therapies being explored for long COVID The importance of continuing research into post-viral illness About Our Guest Dr. Peter McCullough is a board-certified internist, cardiologist, and epidemiologist. Throughout the COVID-19 pandemic he became one of the most recognizable physicians discussing early treatment strategies, vaccine safety, and long COVID. His work has generated both significant attention and controversy within the medical community. Key Takeaway Long COVID is not a one-size-fits-all condition. While researchers continue investigating its underlying mechanisms, patients and clinicians alike are searching for better ways to diagnose, understand, and treat persistent post-viral symptoms. This episode explores one physician's perspective on those ongoing challenges and why continued research remains critical. Resources Mentioned LabCorp COVID antibody testing Research on long COVID and post-viral illness Hyperbaric oxygen therapy (HBOT) Gut microbiome research Mast cell activation syndrome (MCAS) Spike protein detoxification protocols discussed by Dr. McCullough Connect with BS Free MD

Every spring for over 50 years, the Trauma, Critical Care, and Acute Care Surgery conference, best known simply as the MATTOX conference, is held in Las Vegas (https://www.trauma-criticalcare.com/).  The conference is unique in that it is entirely focused on practice-changing clinical education. It's a damn good time too!  A favorite feature is the annual debates.  Today, we are featuring a showdown between Drs. Bryan A. Cotton, MD, MPH and Marty A. Schreiber, MD, FACS, FCCM, FCRST (Hon), COL, MC, USAR as they debate REBOA as a Life-Saving Intervention in Hemorrhagic Shock.  You can listen on the podcast or watch the debate with accompanying slides on our website or app.  Let's get ready to RUMMMBLLLEEEE!  TRAUMA SURGERY VIDEO ATLAS: https://behindtheknife.org/premium/trauma-surgery-video-atlasPreparing for the deadliest injuries is challenging, and currently available resources are limited. That is why we created the Behind the Knife Trauma Surgery Video Atlas. Be ready for the most complex injuries, like penetrating trauma to the neck, audible bleeding from the IVC, and pelvic hemorrhage, with 24 scenarios. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Every spring for over 50 years, the Trauma, Critical Care, and Acute Care Surgery conference, best known simply as the MATTOX conference, is held in Las Vegas (https://www.trauma-criticalcare.com/).  The conference is unique in that it is entirely focused on practice-changing clinical education. It's a damn good time too!  A favorite feature is the annual debates.  Today, we are featuring a showdown between Drs. Carlos V.R. Brown, MD, FACS and Katie W. Russell, MD as they debate WHETHER OR NOT PEDIATRIC PANCREATIC INJURIES CAN BE MANAGED NON-OPERATIVELY.  You can listen on the podcast or watch the debate with accompanying slides on our website or app.  Let's get ready to RUMMMBLLLEEEE!  TRAUMA SURGERY VIDEO ATLAS: https://behindtheknife.org/premium/trauma-surgery-video-atlasPreparing for the deadliest injuries is challenging, and currently available resources are limited. That is why we created the Behind the Knife Trauma Surgery Video Atlas. Be ready for the most complex injuries, like penetrating trauma to the neck, audible bleeding from the IVC, and pelvic hemorrhage, with 24 scenarios. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Join us as we discuss research on mental health and wellbeing in the surgical workforce with Drs. Yang and Collins. The episode explores key findings from recent national surveys showing that nearly one in seven surgeons report suicidal ideation in the past year, with depression, anxiety, and PTSD affecting 15–20% of the surgical population. The conversation highlights protective factors—professional fulfillment, resilience, self-valuation, and connection—while distinguishing between healthy resilience and normalized suffering. Dr. Yang and Dr. Collins discuss systemic barriers including time constraints, out-of-pocket mental health costs, and persistent stigma, alongside actionable institutional interventions: protecting dedicated wellbeing time, establishing peer support and psychological first aid programs, ensuring free mental health access, and expanding research to understand what helps surgeons thrive. The episode emphasizes that self-care is essential to patient safety and invites listeners to become advocates, engage with the literature, and help drive culture change within their institutions. For more information about the AAS wellbeing survey, please email Dr. Yang at CJYANG@MGH.HARVARD.EDU.Host:   Steven Thornton, MD (General Surgery Resident at Duke University) Agnes Premkumar (General Surgery Resident at Creighton) Guests: Jeff Yang, MD (Massachusetts General Hospital) Reagan Collins, MD (University of Pennsylvania) Publications Discussed: Hughes TM, Collins RA, Cunningham CE. Depression and Suicide Among American Surgeons-A Grave Threat to the Surgeon Workforce. JAMA Surg. 2024 Jan 1;159(1):7-8. doi: 10.1001/jamasurg.2023.4658. PMID: 37792380. [https://pubmed.ncbi.nlm.nih.gov/37792380/] Collins RA, Herman T, Snyder RA, Haines KL, Stey A, Arora TK, Geevarghese SK, Phillips JD, Vicente D, Griggs CL, McElroy IE, Wall AE, Hughes TM, Sen S, Valinejad J, Alban A, Swan JS, Mercaldo N, Jalali MS, Chhatwal J, Gazelle GS, Rangel E, Yang CJ, Donelan K, Gold JA, West CP, Cunningham C. Unspoken Truths: Mental Health Among Academic Surgeons. Ann Surg. 2024 Mar 1;279(3):429-436. doi: 10.1097/SLA.0000000000006159. Epub 2023 Nov 23. PMID: 37991182. [https://pubmed.ncbi.nlm.nih.gov/37991182/]  Yaghmour NA, Bynum WE 4th, Hafferty FW, Könings KD, Richter T, Brigham TP, Nasca TJ. Causes of Death Among US Medical Residents. JAMA Netw Open. 2025 May 1;8(5):e259238. doi: 10.1001/jamanetworkopen.2025.9238. Erratum in: JAMA Netw Open. 2025 Jul 1;8(7):e2523489. doi: 10.1001/jamanetworkopen.2025.23489. PMID: 40366660; PMCID: PMC12079293. [https://pubmed.ncbi.nlm.nih.gov/40366660/] Nasca BJ, Hunt ML, Ramirez RT, Eng JS, Li RD, Agarwal G, Bilimoria KY, Hu YY. One is too many: suicidality among general surgery residents. Acad Med. 2025 Dec 24:wvaf105. doi: 10.1093/acamed/wvaf105. Epub ahead of print. PMID: 41819820. [https://pubmed.ncbi.nlm.nih.gov/41819820/] Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US